Finasteride-Induced Inhibition of 5α-Reductase Type 2 Could Lead to Kidney Damage—Animal, Experimental Study

In the pharmacological treatment of prostate cancer, benign prostatic hyperplasia and androgenetic alopecia finasteride is commonly used. This drug inhibits 5α-reductase type 2, which is why finasteride affects androgen homeostasis, since testosterone (T) cannot be reduced to dihydrotestosterone (DH...

Descripción completa

Detalles Bibliográficos
Autores principales: Baig, Mirza Saim, Kolasa-Wołosiuk, Agnieszka, Pilutin, Anna, Safranow, Krzysztof, Baranowska-Bosiacka, Irena, Kabat-Koperska, Joanna, Wiszniewska, Barbara
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2019
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6572442/
https://www.ncbi.nlm.nih.gov/pubmed/31100850
http://dx.doi.org/10.3390/ijerph16101726

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6572442/
https://www.ncbi.nlm.nih.gov/pubmed/31100850
http://dx.doi.org/10.3390/ijerph16101726

Ejemplares similares